Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?

Detalles Bibliográficos
Autores principales: Cortegiani, A., Russotto, V., Raineri, S. M., Gregoretti, G., Giarratano, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086411/
https://www.ncbi.nlm.nih.gov/pubmed/27794360
http://dx.doi.org/10.1186/s13054-016-1521-0
_version_ 1782463734864674816
author Cortegiani, A.
Russotto, V.
Raineri, S. M.
Gregoretti, G.
Giarratano, A.
author_facet Cortegiani, A.
Russotto, V.
Raineri, S. M.
Gregoretti, G.
Giarratano, A.
author_sort Cortegiani, A.
collection PubMed
description
format Online
Article
Text
id pubmed-5086411
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50864112016-11-02 Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why? Cortegiani, A. Russotto, V. Raineri, S. M. Gregoretti, G. Giarratano, A. Crit Care Letter BioMed Central 2016-10-30 /pmc/articles/PMC5086411/ /pubmed/27794360 http://dx.doi.org/10.1186/s13054-016-1521-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Cortegiani, A.
Russotto, V.
Raineri, S. M.
Gregoretti, G.
Giarratano, A.
Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
title Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
title_full Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
title_fullStr Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
title_full_unstemmed Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
title_short Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?
title_sort should we continue to use prediction tools to identify patients at risk of candida spp. infection? if yes, why?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086411/
https://www.ncbi.nlm.nih.gov/pubmed/27794360
http://dx.doi.org/10.1186/s13054-016-1521-0
work_keys_str_mv AT cortegiania shouldwecontinuetousepredictiontoolstoidentifypatientsatriskofcandidasppinfectionifyeswhy
AT russottov shouldwecontinuetousepredictiontoolstoidentifypatientsatriskofcandidasppinfectionifyeswhy
AT rainerism shouldwecontinuetousepredictiontoolstoidentifypatientsatriskofcandidasppinfectionifyeswhy
AT gregorettig shouldwecontinuetousepredictiontoolstoidentifypatientsatriskofcandidasppinfectionifyeswhy
AT giarratanoa shouldwecontinuetousepredictiontoolstoidentifypatientsatriskofcandidasppinfectionifyeswhy

Ejemplares similares